Connect with us

Technology

Hearing Aids Market to Reach US$ 15.3 Bn by 2031, Driven by AI and Growing Accessibility | Wissen Research

Published

on

SHERIDAN, Wyo., Oct. 22, 2026 /PRNewswire/ — 

Hearing Aids Market Outlook: Innovation and Accessibility Drive Growth

“The hearing aids market is evolving rapidly as advances in AI, rechargeable technology, and over-the-counter devices make hearing care more accessible. With the global market projected to reach USD 15.3 billion by 2031, innovation and growing awareness of untreated hearing loss are expected to play a key role in shaping the industry,” said Mayur Jain, Research Expert at Wissen Research.

The need is large. The World Health Organization (WHO) estimates that more than 1.5 billion people worldwide live with hearing loss and about 430 million need rehabilitation for disabling hearing loss, and the report notes the number of people with hearing disorders could reach 2.5 billion by 2050. Aging populations are expanding the pool of users, while noise at work and in leisure activities is adding younger people to it. WHO calls untreated hearing loss a serious public health issue because it limits communication, education, work, and social life.

The report also points to a wide gap between the number of people with hearing loss and the number who use appropriate devices and treatment. That gap is where the industry is competing. Hearing aids have moved from simple sound amplifiers to connected, rechargeable, AI-enabled hearing aids, and a new over-the-counter category in the United States is changing how some adults buy them.

Get a Free Sample of This Report to Explore Key Findings and Data: https://www.wissenresearch.com/request-a-sample/?report=hearing-aids-market 

From Amplifiers to AI: Hearing Aids Now Process Speech, Noise, and Context in Real Time

Modern hearing aids are built from microphones, digital signal processors, amplifiers, receivers, and batteries, and the technology has moved from plain sound amplification to personalized, automatically adjusting listening. Directional microphones prioritize sound coming from certain directions, feedback cancellation and adaptive noise reduction clean up the signal, and processing can now tell speech from background noise and adjust amplification to the acoustic setting.

The hardest test is a crowded room, where background conversation and ambient noise make speech difficult to follow. The report notes that how well hearing aids cope with that depends on factors such as device design, which is why manufacturers keep working on speech enhancement. The race is visible in recent launches. In August 2026, three of the five companies the report names as top players, Sonova, Demant, and WS Audiology, each introduced a new platform built around AI that processes speech and surrounding sound in real time.

Over-the-Counter, Rechargeable, and Connected: Hearing Aids Become a Consumer Product

The second shift is about access. The U.S. Food and Drug Administration (FDA) has defined a category of over-the-counter (OTC) hearing aids for adults over 18 with mild to moderate hearing impairment, who can buy them in a store or online without a prescription or fitting appointment. The report sees this opening the door to self-fitting technology, easier-to-use devices, lower-priced products, and more consumer-oriented distribution. OTC devices are not right for every case, however, and children and people who need specialized assessment still require professional fitting.

Convenience features are changing expectations as well. Rechargeable hearing aids remove the need for frequent battery purchases, Bluetooth lets users stream calls and audio from compatible devices, and smartphone apps handle volume, listening preferences, and device settings. Remote fitting and teleaudiology services add support without a clinic visit. These features are especially helpful for older users and anyone who wants a simpler device.

What’s Fueling Growth in the Hearing Aids Market

Rising prevalence of hearing loss: Aging populations and noise exposure at work and in leisure activities are expanding the number of potential users.Greater awareness of hearing care: Consumers and health professionals increasingly recognize how hearing loss affects communication, social life, and quality of life, which encourages earlier evaluation and treatment.Better sound technology: Improvements in personalization, directionality, noise reduction, feedback control, and adaptability make it easier for users to follow sound in different listening environments.Rechargeable and smart devices: Rechargeable batteries, smartphone compatibility, wireless audio streaming, and easy pairing of devices remove daily frustrations.More ways to buy: Audiology clinics, specialty shops, online stores, and OTC devices, where regulations allow, are widening access.Demand for customized products: Manufacturers are offering more styles, form factors, and technologies to match individual needs.

Challenges Facing the Hearing Aids Market

The biggest challenge is the gap between those who have hearing loss and those who use appropriate devices and care. High costs of devices and fitting, limited coverage from public programs, low awareness, stigma, and limited access to hearing specialists can all slow adoption.

Results also vary from person to person, depending on the type and degree of hearing loss, the device chosen, the fitting method, and the listening environment. Even advanced devices can struggle in noise, and some users have discomfort, trouble handling small devices, or difficulty adapting to amplification. Manufacturers must also balance reliability and pricing with battery life, wireless technology, cybersecurity, safety, and regulatory compliance.

Recent Strategic Developments in the Hearing Aids Market

In August 2026, Sonova launched its Phonak EON hearing aid platform, featuring real-time artificial intelligence to improve speech understanding and reduce listening effort. The company positioned the smaller, lighter device in the premium segment, launching first in the United States, followed by Australia and key European markets.

In August 2026, Demant A/S of Denmark introduced Oticon Reveal, a platform with Dual AI technology that processes speech and contextual sounds simultaneously in real time. The platform also adds improved feedback control and enhanced wireless connectivity, aiming to improve speech understanding and deliver a more natural listening experience.

In August 2026, WS Audiology A/S of Denmark introduced Signia’s Multi-adaptive Xperience (MaX) platform, which integrates four deep neural networks to process speech, background noise, environmental sounds, and the wearer’s own voice simultaneously. It also offers enhanced group-conversation processing, improved computing power, rechargeable functionality, and expanded Bluetooth and Auracast connectivity.

All three launches lean on AI to separate speech from everything else, and all three add connectivity.

Key Insights from Hearing Aids Market Analysis

Hearing aid devices held a leading position by product type in 2025. The category covers behind-the-ear, receiver-in-canal, in-the-ear, in-the-canal, and completely-in-canal devices. Hearing implants, including cochlear implants and bone-anchored hearing systems, are the other category, serving patients who do not get enough benefit from conventional hearing aids, and their use depends on qualification, medical assessment, surgery, rehabilitation, and reimbursement.Digital hearing aids held a leading position by technology type in 2025, because digital signal processing allows personalized amplification across different frequencies and makes features such as feedback cancellation, directional microphones, and adaptive noise reduction possible. Analog devices are used less often today.North America is the leading region, supported by developed hearing care infrastructure, specialized distribution channels, advanced hearing technologies, and the U.S. OTC category.Asia Pacific is the fastest-growing region, supported by large and aging populations, rising awareness of hearing impairment, and gradually expanding hearing care facilities. China, India, and Japan are the most important national markets, each with a different level of healthcare access, purchasing power, device adoption, and audiology infrastructure.The market is moderately consolidated, with a small group of established manufacturers holding significant competitive positions, supported by established brands, extensive distribution networks, proprietary hearing technologies, and relationships with hearing care professionals. Smaller manufacturers and emerging consumer-focused companies compete in specialized and price-sensitive segments.

Key Players in the Hearing Aids Market

Leading companies in the hearing aids market are focusing on digital signal processing, rechargeable devices, wireless connectivity, personalized fitting, speech enhancement, and expansion across professional and consumer-oriented distribution channels.

The report names Sonova AG (Switzerland), Demant A/S (Denmark), WS Audiology A/S (Denmark), GN Store Nord A/S (Denmark), and Starkey Laboratories, Inc. (US) as the top five players, participating through hearing aid devices, digital sound-processing technologies, connectivity features, and hearing care solutions. Competition turns on sound quality, comfort, battery duration, connectivity, fitting accuracy, price, availability through distribution channels, and consumer support.

Other companies profiled in the report include Cochlear Limited (Australia), MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. (Austria), RION Co., Ltd. (Japan), Eargo, Inc. (US), and Audina Hearing Instruments, Inc. (US). The report also covers Amplifon S.p.A., Audicus, Inc., Nuheara Limited, Earlens Corporation, Etymotic Research, Inc., IntriCon Corporation, hearX Group, and Sound World Solutions, LLC, among others.

Regional Analysis and Growth Opportunities

North America leads the hearing aids market. The report points to developed hearing care infrastructure, specialized distribution channels, and advanced hearing technologies in North America and Europe, and to the FDA’s OTC category, which created a prescription-free route to hearing aids for adults with mild to moderate hearing loss.

Asia Pacific is the fastest-growing region. Its large and aging population, rising awareness of hearing health, and gradually expanding healthcare infrastructure support demand, with China, India, and Japan the most important national markets because of their population size and rising need for hearing care services. WHO stresses that hearing loss should be treated as an important public health issue and that access to diagnosis, treatment, and assistive technologies should improve. Growth in specialized hearing clinics, hospitals, retailers, and online channels, along with improvements in digital, wireless, and rechargeable devices, is helping make hearing aids more accessible in the region, although high costs, low awareness, limited access to specialists, and differences in reimbursement continue to limit adoption.

Europe, Latin America, and the Middle East & Africa complete the report’s regional coverage.

Get a Custom Briefing on This Market for Your Business

Wissen Research’s healthcare technology analysts are available to walk through findings specific to your market, region, or competitive set.

Need Insights Specific to Your Business? Request a Customized Version of This Report: https://www.wissenresearch.com/request-customization/?report=hearing-aids-market 

Market Segmentation Snapshot

The global hearing aids market is segmented across product type, patient type, technology type, hearing loss type, distribution type, and region:

By Product Type:Hearing Aid Devices (Receiver-in-the-Ear/RIC Hearing Aids, Behind-the-Ear/BTE Hearing Aids, Canal Hearing Aids, In-the-Ear/ITE Hearing Aids, Other Hearing Aid Devices)Hearing Implants (Cochlear Implants, Bone-Anchored Hearing Systems)By Patient Type:AdultsPaediatricsBy Technology Type:DigitalAnalogBy Hearing Loss Type:Sensorineural Hearing LossConductive Hearing LossBy Distribution Type:Audiology and ENT Hospitals & ClinicsRetail & Pharmacy StoresOnline SalesBy Region:North AmericaEuropeAsia-PacificLatin AmericaMiddle East & Africa

Frequently Asked Questions

Q: What is the size of the hearing aids market? 
A: The global hearing aids market is estimated at USD 10.9 billion in 2026 and is projected to reach USD 15.3 billion by 2031.

Q: What is the growth rate of the hearing aids market? 
A: The hearing aids market is projected to grow at a CAGR of 7% between 2026 and 2031.

Q: What are hearing aids? 
A: Hearing aids are electronic devices that capture, process, amplify, and transmit sound, making it audible to people with different degrees and types of hearing loss. The main styles are behind-the-ear, receiver-in-canal, in-the-ear, in-the-canal, and completely-in-canal devices, and many now include digital processing, rechargeable batteries, Bluetooth connectivity, and AI-assisted sound processing.

Q: How many people have hearing loss? 
A: According to the World Health Organization, more than 1.5 billion people worldwide live with hearing loss, and about 430 million need rehabilitation for disabling hearing loss.

Q: What are over-the-counter hearing aids? 
A: In the United States, the FDA has defined a category of over-the-counter hearing aids for adults over 18 with mild to moderate hearing impairment, who can buy them in a store or online without a prescription. They are not suitable for all types and degrees of hearing loss, and children and people who need specialized assessment still require professional diagnosis and fitting.

Q: Which technology leads the hearing aids market? 
A: Digital hearing aids held a leading position by technology type in 2025, because digital signal processing allows personalized amplification and features such as feedback cancellation, directional microphones, and adaptive noise reduction.

Q: Which product type leads the hearing aids market? 
A: Hearing aid devices, which include behind-the-ear, receiver-in-canal, in-the-ear, in-the-canal, and completely-in-canal styles, held a leading position by product type in 2025, ahead of hearing implants such as cochlear implants.

Q: Which region leads the hearing aids market? 
A: North America is the leading region in the hearing aids market, while Asia Pacific is the fastest-growing region through 2031.

Q: Who are the top players in the hearing aids market? 
A: Leading companies in the hearing aids market include Sonova AG, Demant A/S, WS Audiology A/S, GN Store Nord A/S, and Starkey Laboratories, Inc.

The report describes a shift from amplifying sound to understanding it, and from a product sold through clinics to one that can also be bought off the shelf. For manufacturers, the work ahead is delivering hearing aids that perform in noisy real-world settings, stay affordable, and reach the many people who have hearing loss but do not yet use a device.

Get the Complete Hearing Aids Market Report – Forecasts, Insights & Growth Opportunities: https://www.wissenresearch.com/market-research-reports-pricings/hearing-aids-market

Expert Profile | Mayur Jain, Wissen Research 

Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry. 

Email: mayur@wissenresearch.com
LinkedIn:  https://www.linkedin.com/in/mayur-jain-0190542a/ 

About Wissen Research

Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets

Company Contact:

Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: info@wissenresearch.com
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/hearing-aids-market-to-reach-us-15-3-bn-by-2031–driven-by-ai-and-growing-accessibility–wissen-research-302917351.html

Continue Reading

Technology

Warhound Launches with $200 Million to Rebuild America’s Military Working Dog Supply, Using Advanced Genetics and Defense Technology

Published

on

By

Company will produce genetically enhanced working dogs that leverage cybernetics technology to improve health and performance while ending reliance on foreign suppliers

DALLAS and COSTA MESA, Calif., Oct. 23, 2026 /PRNewswire/ — Warhound, a new defense technology company conceived by American technology entrepreneurs Ben Lamm and Palmer Luckey emerged from stealth with a $200 million seed round. Warhound will rebuild America’s domestic supply of elite working dogs for U.S. military forces, law-enforcement, emergency first response teams—a critical national security resource that the U.S. has long relied on foreign countries to provide. Led by CEO David Spirk, the company will reduce dependence on a shrinking European supply chain and strengthen America’s ability to protect its own people, infrastructure, and national security interests.

Warhound is modernizing America’s working-dog program by delivering a vertically integrated program, combining Colossal’s enhanced genetics platform and secure biobanking capabilities of America’s top-performing dog arsenal, controlled delivery through cloning with best-in-class training and animal care. Through a partnership, all dogs will be equipped by Anduril’s advanced cybernetic Augments, software, and battlefield situational awareness. The company is backed by In-Q-Tel, Sequoia Capital, ARK Invest, Franklin Templeton, 8VC, USIT, Bob Nelsen, Breyer Capital, CAZ Investments, Neogenesis, Builders VC, and Lux Capital among others. Based in Texas, Warhound will operate under the guidance of the American Humane Society which will certify its training programs and support the reunification of retired military working dogs with their former handlers and adoption protocols.

“Palmer, Ben and the Warhound team are exceptional. Sequoia is proud to back them,” said Shaun Maguire, Partner at Sequoia Capital.

Warhound is bringing together Colossal’s breakthroughs in genetics, cloning, and animal biology with Anduril’s advanced defense technology to fundamentally change how America produces, trains, and protects its military working dogs. Colossal’s science will help produce healthier dogs with characteristics suited to demanding missions, while Anduril’s technology will give dogs and their handlers greater awareness and protection in the field.

“Every day, we ask dogs to put their lives on the line to protect ours. They detect explosives, protect our troops, and run toward dangers that most people are trained to run away from. Yet we’re still relying on outdated approaches to breeding and training these extraordinary animals, with too many never making it through the process. We have an opportunity to fundamentally change that. Colossal has spent years pioneering breakthroughs in genetics, cloning, and animal biology, and now we’re applying that science to give these dogs the best possible chance at a long, healthy life and a successful mission. If we’re going to ask man’s best friend to protect America, we owe it to them to use every tool at our disposal to protect them, too,” said Ben Lamm.

Since the Army established the K-9 Corps in 1942, military working dogs have served alongside America’s armed forces for more than 84 years—detecting threats, protecting service members and supporting missions worldwide. That program has evolved in The United States Department of War’s (DOW) Military Working Dog Program, which currently includes 2,200+ working dog teams that are operationally critical for detection and patrol work, and a critical part of the defense infrastructure of the country. More than 80% of U.S. military working dogs are currently acquired from Europe, creating a critical interdependency on foreign nations for an asset the Pentagon itself calls irreplaceable. That dependency is compounding: after a rigorous, roughly three-year acquisition-and-training pipeline, less than half of the dogs procured are ultimately deemed fit for service, meaning the U.S. must source and train roughly 200 dogs today to field 100 working animals tomorrow.

“Man’s best friend deserves man’s best tech,” said Palmer Luckey. 

David Spirk has been named the CEO of Warhound. As a veteran of the United States Marine Corps, he worked as an intelligence specialist with multiple deployments and ultimately served as the Deputy Associate Director of National Intelligence for Afghanistan and Pakistan at the Office of the Director of National Intelligence representing the Intelligence Community at the White House and on Capital Hill. He has an extensive background in the U.S. military, intelligence community, and federal data governance, specifically focused on scaling algorithmic warfare and creating data driven advantages. More recently, he was a Senior Counselor at Palantir Technologies where he focused on expanding the company’s software footprints across the U.S. government, allied international partners, and commercial sectors. Previously, he was appointed the First Chief Data Officer (CDO) for the Department of War, where he worked on accelerating the military’s data-driven capabilities and was the first CDO for the U.S. Special Operations Command (USSOCOM).

“Our long-term goal is simple: healthier dogs, better-prepared teams, and more service members and first responders coming home safely. Leading Warhound, and strengthening America’s working-dog capabilities, is an opportunity to apply my experience to a mission I care deeply about: protecting people and helping the animals who support them,” said David Spirk. “My focus is building a team that can turn scientific advances into capabilities that work in the field.”

Building Healthier, More Capable Working Dogs to Protect Both Dogs and People
The concept of Warhound was conceived years ago by Palmer and Ben after a discussion at Peter Diamandis’ Moonshots Summit. Military working-dog programs face a costly challenge: more than half of candidate dogs fail to complete training, while reliance on overseas breeders leaves the United States dependent on a constrained foreign supply chain. Warhound was created to improve that system—producing fewer dogs with a greater likelihood of remaining healthy, completing training, and succeeding in their missions.

Warhound dog-and-handler teams will also connect Anduril’s integrated capabilities—including eye and ear protection and Eagle Eye technology—will help safeguard working dogs, their handlers and the wider unit while supporting safer, more effective missions.

“For millennia, people have selectively bred dogs to be companions and helpmates. Modern biotechnology gives us a more precise way to shape some of their traits, thus improving both the work dogs do and their own health and well-being,” said Alta Charo, Warren P. Knowles Professor Emerita of Law and Bioethics at the University of Wisconsin–Madison. “The Warhound project offers the possibility of improving working dogs’ health and welfare while supporting the lifesaving work they do. But we still must look carefully at who benefits, what risks the animals bear, and how concern for animal welfare translates into practice through careful evaluation of the evidence, meaningful oversight, and responsibility for the dogs throughout their lives, including retirement. The American Humane Society brings valuable experience through its military working dog reunification efforts and Pups4Patriots program. That experience provides a foundation, but public trust has to be earned through the care we provide and the commitments we keep.”

Animal welfare is central to the program. By improving health, durability, and training success, Warhound will significantly reduce washouts, limit the number of dogs unnecessarily entering intensive training and enable safer, more effective missions. Technologies and therapeutics developed through the program will also be made available to all dogs and ultimately improve the health of all dogs, not only those serving alongside America’s service men and women. Together, these capabilities will establish a secure domestic supply of military working dogs while giving American service members healthier, more capable canine partners.

“Working dogs are extraordinary animals whose courage and loyalty save lives,” said Dr. Robin Ganzert, President and CEO of American Humane Society. “We owe these dogs a commitment to their well-being that matches their service to us. What excites me about Warhound is the opportunity to make health, welfare, and exceptional care fundamental to a working-dog program from the very beginning. Success means helping these dogs thrive throughout their lives—from training and active service to the loving, dignified retirement every canine hero deserves.”

Warhound is built to take today’s level of performance and make it better: using cutting edge engineering and technology, on American soil, from American companies, without the wait times, price volatility, or geopolitical exposure of a foreign supply chain.

About Warhound
Warhound is a Texas-based defense technology company building a secure domestic supply of healthier, more capable working dogs for the U.S. military, law enforcement and emergency responders. Conceived by Palmer Luckey and Ben Lamm, Warhound combines biotechnology licensed from Colossal Biosciences with advanced training and Anduril’s cybernetic augments and software. The company aims to reduce reliance on foreign suppliers, improve canine health and performance, and enhance safety for dogs and their handlers. Animal welfare is central to Warhound’s mission, with a commitment to lifelong care from birth through training, service and retirement. To follow along, please visit: warhound.com.

About Anduril
Anduril Industries is a defense technology company that builds autonomous systems and a common operating layer to give the United States and its allies a persistent advantage in sensing, decision-making, and force projection.

About the American Humane Society
The American Humane Society is the country’s first national humane organization and a global leader in animal welfare. Founded in 1877, American Humane has been at the forefront of protecting animals, rescuing them from cruelty, abuse, and natural disasters, and setting the gold standard in science-based welfare certifications. The organization oversees prominent programs including the iconic “No Animals Were Harmed®” film and television certification, the American Humane Certified™ farm and zoo standards, military working dog reunifications, and the Pups4Patriots™ service dog program. Learn more at americanhumane.org. 

About Colossal Biosciences
Colossal was founded by emerging technology and software entrepreneur Ben Lamm and world-renowned geneticist and serial biotech entrepreneur George Church, Ph.D., and is the first to apply CRISPR technology for the purposes of species de-extinction. Colossal creates innovative technologies for species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies. To follow along, please visit: www.colossal.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/warhound-launches-with-200-million-to-rebuild-americas-military-working-dog-supply-using-advanced-genetics-and-defense-technology-302918435.html

SOURCE Warhound

Continue Reading

Technology

Best Version Media Names Chris Laurence Next CEO; Kevin O’Brien Transitions to CRO

Published

on

By

Leadership investment strengthens companywide execution and sharpens focus on Publisher success and revenue growth

BROOKFIELD, Wis., Oct. 23, 2026 /PRNewswire/ — Best Version Media (BVM), a local media and marketing company serving more than 1,300 communities across the United States and Canada, today announced that Chris Laurence has joined the company as Chief Executive Officer. Kevin O’Brien, who previously served as CEO, will transition to Chief Revenue Officer, focusing on leading BVM’s sales field and accelerating revenue growth.

The appointments reflect BVM’s investment in leadership to support its next stage of growth. By establishing dedicated executive leadership for the broader organization and the sales field, BVM is strengthening its ability to execute across the business while supporting its independent Publishers and the local businesses they serve.

“Our growth has brought us to a point where leading the overall company and leading our sales field each deserve a dedicated focus,” said O’Brien. “This transition allows me to concentrate on working with our sales leaders and Publishers, strengthening the field, and helping more local businesses connect with their communities. I’m excited to partner with Chris as we build on BVM’s momentum.”

Laurence brings experience as CEO, CFO, and COO of public, private, and private equity-backed companies, where he has led growth, operational improvement, and technology transformation. Before moving into operating roles, he was a general partner at Brentwood Associates, a Los Angeles-based private equity firm.

“BVM has built a powerful combination of community storytelling, local relationships, and marketing solutions for small businesses,” said Laurence. “I look forward to working with Kevin and the entire team to build on that foundation, strengthen how we operate, and support the success of our Publishers and clients.”

As CEO, Laurence will lead BVM’s overall strategy and operations, working with the team to scale operations and support the success of our Publishers and the local businesses they serve. As CRO, O’Brien will focus on sales leadership, Publisher growth, and revenue generation. Together, they will help advance BVM’s print and digital offerings and position the company for continued growth.

About Best Version Media

Founded in 2007, Best Version Media (BVM) connects local businesses with customers through community magazines, targeted digital advertising, and online presence management tools. Serving more than 1,300 communities across the United States and Canada, BVM’s network of independent Publishers builds relationships with local businesses and brings community stories to life. BVM is a portfolio company of H.I.G. Capital. To learn more, visit www.bestversionmedia.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/best-version-media-names-chris-laurence-next-ceo-kevin-obrien-transitions-to-cro-302918458.html

SOURCE Best Version Media, LLC

Continue Reading

Technology

Dow and Small Caps Climb Weekly While Nasdaq Slips on Megacap Earnings Charges

Published

on

By

VANCOUVER, BC, Oct. 23, 2026 /PRNewswire/ — Stock Preachers News Commentary – Stocks closed a volatile earnings week with a split verdict: the Dow gained 0.64% and the Russell 2000 jumped 2.07%, while the Nasdaq Composite fell 0.45% and the S&P 500 slipped 0.22%. The VIX rose to 19.40 and the VXN climbed to 28.13 as traders weighed a wave of third-quarter results. Gold dropped 3.47% and silver fell 4.90% on the week, while WTI crude rose 3.74% on Thursday alone. The 10-year Treasury yield eased 11 basis points to 4.99%. Active Companies from around the markets with current developments this week include: Meta Platforms, Inc. (Nasdaq: META), Texas Instruments Incorporated (Nasdaq: TXN), RTX (NYSE: RTX), IBM (NYSE: IBM), and First Citizens BancShares, Inc. (Nasdaq: FCNCA).

Large-cap benchmarks diverged sharply this week. The Dow closed at 52,337.54, up 0.64% for the week despite a 1% drop on Friday, while the S&P 500 ended at 7,642.22, down 0.22% weekly after touching a week high of 7,770.40. The Nasdaq Composite settled at 26,022.45, down 0.45% on the week, dragged by a rough stretch for megacap tech following a batch of earnings reports.

The Russell 2000 was the standout, closing at 2,777.63 for a 2.07% weekly gain, outperforming its large-cap peers as investors rotated toward smaller names. RSI readings show the Nasdaq at 38.9 and the S&P 500 at 43.5, both in cooler territory, while the Dow’s RSI of 54.1 reflects its relative strength this week.

Volatility ticked higher into the weekend, with the VIX up 0.96 points for the week to 19.40 and the VXN up a full point to 28.13. In commodities, natural gas spiked 8.66% on Thursday alone even as it remained down 0.65% for the week, while copper rose 2.44% daily. The dollar firmed slightly against the euro, with EUR/USD down 0.24% on the week to 1.12.

The full report also breaks down key support and resistance levels for each index, additional earnings movers, and sentiment heading into next week’s sessions.

CONTINUED… Read this and more news for Meta Platforms, Inc. (Nasdaq: META), Texas Instruments Incorporated (Nasdaq: TXN), RTX (NYSE: RTX), IBM (NYSE: IBM), and First Citizens BancShares, Inc. (Nasdaq: FCNCA) at: https://stockpreachers.com/articles/small-caps-lead-big-tech-lags-as-earnings-season-shakes-the-tape/

In other industry developments and happenings in the market this week include:

Meta Platforms, Inc. (Nasdaq: META) Meta reported third-quarter revenue of $64.60 billion, up 26% year over year, but net income of $9.86 billion reflected a $9.89 billion charge tied to an agreement with 52 state attorneys general over teen mental health and social media litigation. Diluted EPS was $3.83, up 265% year over year; excluding the litigation charge, EPS would have been $7.40.

Operating margin fell to 20% from 40% a year earlier, while costs and expenses rose 68% to $51.61 billion. Capital expenditures, including finance lease payments, totaled $34.91 billion, and free cash flow was negative $2.12 billion for the quarter.

“We hit major milestones this quarter toward delivering personal superintelligence for everyone – including launching Muse and Muse Wonder, our first frontier model,” said Mark Zuckerberg, Meta founder and CEO. “Our investments are paying off, the core business is strong, and we’re seeing velocity across the board.” The company guided fourth-quarter revenue to a range of $73-76 billion and raised full-year 2026 total expense guidance to $175-179 billion. Read the release.

Texas Instruments Incorporated (Nasdaq: TXN) Texas Instruments reported third-quarter revenue of $6.06 billion, up 28% from a year earlier, with net income of $2.43 billion and earnings per share of $2.62. Operating profit rose 73% to $2.87 billion, and revenue increased 11% sequentially.

“Revenue increased 11% sequentially and 28% from the same quarter a year ago with continued broad growth in industrial, automotive and data center,” said Haviv Ilan, TI’s chairman, president and CEO. Trailing 12-month cash flow from operations was $9.9 billion, with free cash flow of $8.4 billion.

The company returned $5.8 billion to shareholders over the trailing 12 months and guided fourth-quarter revenue to a range of $5.80 billion to $6.30 billion, with earnings per share expected between $2.45 and $2.79. Read the release.

RTX (NYSE: RTX) RTX reported third-quarter sales of $25.0 billion, up 11% versus the prior year and 12% organically, with adjusted EPS of $2.26, up 33% from a year earlier. GAAP EPS was $1.89. Operating cash flow was $2.9 billion and free cash flow was $2.1 billion, with results including $0.25 of IEEPA cost recovery per share.

The company’s backlog reached a record $340 billion, including $176 billion commercial and $164 billion defense, after over $81 billion of new awards including Tomahawk and AMRAAM multi-year production contracts.

“Our strong execution and operational focus in the third quarter enabled RTX to deliver double-digit organic sales growth across commercial aerospace and defense,” said RTX Chairman and CEO Chris Calio. The company raised its full-year adjusted EPS outlook to $7.65-$7.75 and adjusted sales guidance to $97.0-$97.5 billion. Read the release.

IBM (NYSE: IBM) IBM reported third-quarter revenue of $17.1 billion, up 5% as reported and 6% at constant currency, with Software revenue up 8% and Infrastructure revenue up 4%. GAAP diluted earnings per share were $2.31, up 26% year over year, while operating (non-GAAP) EPS was $2.95, up 11%.

The company generated $4.0 billion in net cash from operating activities in the quarter and $3.0 billion in free cash flow, up $0.7 billion year over year. Year to date, free cash flow reached $7.8 billion.

“Disciplined execution throughout the quarter drove accelerated revenue growth and strong free cash flow,” said Arvind Krishna, IBM chairman, president and chief executive officer. IBM now expects full-year free cash flow to increase by more than $1 billion year over year, while continuing to guide constant currency revenue growth of four to five percent. Read the release.

First Citizens BancShares, Inc. (Nasdaq: FCNCA) First Citizens BancShares reported third-quarter net income of $606 million, down from $672 million in the linked quarter. Net income available to common stockholders was $577 million, or $51.23 per common share, a $63 million decrease from the prior quarter’s $640 million.

Net interest income rose to $1.70 billion, up $43 million from the linked quarter, while net interest margin declined 3 basis points to 3.07%. The company completed its BMO Branch Acquisition on September 4, 2026, assuming approximately $4.9 billion in deposits and acquiring approximately $650 million in loans.

“We returned $600 million to our stockholders through share repurchases and further optimized our balance sheet by repaying another $8.0 billion of the Purchase Money Note,” said Chairman and CEO Frank B. Holding, Jr. The board approved a new repurchase plan authorizing up to $1.2 billion of Class A common shares through 2027. Read the release.

Contact Information:

https://stockpreachers.com

Media Contact: info@stockpreachers.com

DISCLAIMER: Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a market commentary and is not a paid advertisement. This article is being distributed by Stock Preachers, which is wholly owned and operated by Market Equities Limited (“MEL”), a company incorporated under the laws of Ireland. This is an independent market commentary published on a non-paid basis. MEL has not been paid any fee by any company mentioned in this article for its production or distribution, and MEL has no advertising or digital media agreement with any company mentioned in this article. The companies mentioned have not reviewed or approved this article. Market Equities and its owners, operators, directors, and affiliates may, from time to time, hold positions in securities mentioned in this article or in the broad-market index funds that track them, and reserve the right to buy, sell, or hold such securities at any time without further notice. Information in this article was obtained from sources believed to be reliable, including company news releases and public market data, but its accuracy cannot be guaranteed. Market data is as of the time stated and may be delayed. Portions of this commentary were produced with the assistance of automated tools from that data and reviewed against it. Investing in securities involves risk, including the possible loss of some or all of your investment. Technical analysis describes past price and volume behavior and does not predict future results; support and resistance levels can fail at any time. References to the companies named in this article are provided solely as market and sector context and as summaries of each company’s own public news releases. No partnership, affiliation, or endorsement is implied, and nothing in this article is a recommendation to buy, sell, or hold any security. Quotations attributed to company executives are reproduced from those companies’ own news releases. Forward-Looking Statements: This article may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements made by the companies mentioned in their own news releases. Such statements involve risks and uncertainties, and actual results may differ materially. Readers should review each company’s filings with the SEC and applicable Canadian securities regulators. Eagle Eye is an investor signal-intelligence platform affiliated with the publisher of this article. Eagle Eye is not a broker-dealer, and nothing it provides is investment advice. Data may be delayed. Always do your own research.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-and-small-caps-climb-weekly-while-nasdaq-slips-on-megacap-earnings-charges-302918459.html

SOURCE Stock Preachers

Continue Reading

Trending